- Home
- GEVO vs RXST Comparison
GEVO vs RXST Comparison
Compare GEVO & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEVO
- RXST
- Stock Information
- Founded
- GEVO 2005
- RXST 1997
- Country
- GEVO United States
- RXST United States
- Employees
- GEVO N/A
- RXST N/A
- Industry
- GEVO Major Chemicals
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- GEVO Industrials
- RXST Health Care
- Exchange
- GEVO Nasdaq
- RXST Nasdaq
- Market Cap
- GEVO 418.4M
- RXST 347.8M
- IPO Year
- GEVO 2011
- RXST 2021
- Fundamental
- Price
- GEVO $1.67
- RXST $8.89
- Analyst Decision
- GEVO Buy
- RXST Hold
- Analyst Count
- GEVO 2
- RXST 11
- Target Price
- GEVO $7.58
- RXST $11.80
- AVG Volume (30 Days)
- GEVO 9.5M
- RXST 1.3M
- Earning Date
- GEVO 11-06-2025
- RXST 11-06-2025
- Dividend Yield
- GEVO N/A
- RXST N/A
- EPS Growth
- GEVO N/A
- RXST N/A
- EPS
- GEVO N/A
- RXST N/A
- Revenue
- GEVO $80,187,000.00
- RXST $147,059,000.00
- Revenue This Year
- GEVO $909.99
- RXST N/A
- Revenue Next Year
- GEVO $22.37
- RXST $6.71
- P/E Ratio
- GEVO N/A
- RXST N/A
- Revenue Growth
- GEVO 341.75
- RXST 27.68
- 52 Week Low
- GEVO $0.67
- RXST $6.32
- 52 Week High
- GEVO $3.39
- RXST $57.53
- Technical
- Relative Strength Index (RSI)
- GEVO 53.71
- RXST 52.43
- Support Level
- GEVO $1.54
- RXST $8.29
- Resistance Level
- GEVO $1.80
- RXST $9.25
- Average True Range (ATR)
- GEVO 0.10
- RXST 0.50
- MACD
- GEVO -0.02
- RXST 0.10
- Stochastic Oscillator
- GEVO 40.62
- RXST 58.97
About GEVO Gevo Inc.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.